Publication date | Issuer | Person discharging managerial responsibilities | Position | Closely associated | Nature of transaction | Instrument name | Intrument type | ISIN | Transaction date | Volume | Unit | Price | Currency | Status | Details |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
28/06/2024 | Oncopeptides AB | Ulf Jungnelius | Member of the Board of Directors | Allotment | Oncopeptides AB | Share | SE0009414576 | 28/06/2024 | 43,292 | Quantity | 0.00 | SEK | Notification | ||
28/06/2024 | Oncopeptides AB | Per Wold-Olsen | Chairman of the Board of Directors | Allotment | Oncopeptides AB | Share | SE0009414576 | 28/06/2024 | 108,231 | Quantity | 0.00 | SEK | Notification | ||
27/06/2024 | Oncopeptides AB (publ) | Cecilia Daun Wennborg | Member of the Board of Directors | Allotment | Share | Share | SE0009414576 | 27/06/2024 | 43,292 | Quantity | 0.00 | SEK | Notification | ||
21/05/2024 | Oncopeptides AB | Stefan Norin | Other member of the company's administrative, management or supervisory body | Acquisition | Oncopeptides AB Allocation | Share | SE0009414576 | 07/05/2024 | 5,000 | Quantity | 2.60 | SEK | History | Notification | |
07/05/2024 | Oncopeptides AB | Stig Anders Jacob Lindberg | Other senior executive | Subscription | Oncopeptides AB BTA | BTA | SE0021924370 | 03/05/2024 | 1,090,708 | Quantity | 2.60 | SEK | Notification | ||
06/05/2024 | Oncopeptides AB | Per Wold-Olsen | Chairman of the Board of Directors | Subscription | Oncopeptides BTA | BTA | SE0021924370 | 03/05/2024 | 519,180 | Quantity | 2.60 | SEK | Notification | ||
06/05/2024 | Oncopeptides AB | Sofia Heigis | Chief Executive Officer (CEO)/Managing Directory | Subscription | Oncopeptides AB BTA | BTA | SE0021924370 | 03/05/2024 | 66,804 | Quantity | 2.60 | SEK | History | Notification | |
06/05/2024 | Oncopeptides AB | David Augustsson | Other member of the company's administrative, management or supervisory body | Subscription | Oncopeptides BTA | BTA | SE0021924370 | 03/05/2024 | 9,332 | Quantity | 2.60 | SEK | Notification | ||
06/05/2024 | Oncopeptides AB | Henrik Bergentoft | Chief Financial Officer (CFO) | Subscription | Oncopeptides BTA | BTA | SE0021924370 | 03/05/2024 | 13,332 | Quantity | 2.60 | SEK | Notification | ||
04/05/2024 | Oncopeptides AB | Sofia Heigis | Chief Executive Officer (CEO)/Managing Directory | Acquisition | Oncopeptides AB BTA | BTA | SE0021924370 | 03/05/2024 | 66,804 | Quantity | 2.60 | SEK | Revised | Notification |